Expression levels differed between the two groups of urothelial carcinomas: low (G1-2) and high-grade tumors (G2-3), with high-grade tumors showing less intensive cytoplasmic immunohistochemical reactions with CK20 than low-grade ones. This evidence concerns the gene KRT20 and urothelial carcinoma.